---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-021186"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-05T00:02:14.793184+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma details $1M share repurchase: open market buys via 10b5-1 plan over 12 months

## Summary
- Board authorized up to $1,000,000 in common stock repurchases (first announced Jan 30, 2024).
- Repurchases expected via open market trades at prevailing prices under a Rule 10b5-1 plan.
- Company will use existing cash reserves; plan may be modified or terminated based on market conditions.
- Expected to occur within the next 12 months.

## SEC filing metadata
- accession: 0001213900-24-021186
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/0001213900-24-021186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/ea0201472-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-021186
- JSON: https://secwatch.observer/filing/0001213900-24-021186.json
- Plain text: https://secwatch.observer/filing/0001213900-24-021186.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.